Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intervention of Bladder Cancer by CAR-T — Stella

Home/Bladder Cancer/Intervention of Bladder Cancer by CAR-T

View on ClinicalTrials.gov

Recruiting

Back to Bladder Cancer trials

Intervention of Bladder Cancer by CAR-T

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

China

Shenzhen Second People Hospital, Shenzhen, Gongdong

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong

Key details

Phase

Early testing / Safety & dosing

Sponsor

Shenzhen Geno-Immune Medical Institute

Enrollment target

~20 participants

Started

August 2025

Primary completion

December 2028

Age range

18 Years – 65 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.